HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nestlé's Iron Deficiency Supplement Among Latest EU Novel Food Authorizations

Executive Summary

A new source of iron manufactured by Nestlé is one of four novel foods to receive authorization by the European Commission for use in dietary supplements.

You may also be interested in...



Protein-Rich Aquatic Plant Secures EU Novel Food Nod

The European Food Safety Authority has judged that Rubsico’s water lentils-based protein concentrate is safe as a novel food for use in dietary supplements and other products.

Insect-Based Supplements Coming To EU Following Novel Food Authorization

Insect-based supplements are coming to the European Union following the authorization by the Commission of Ynsect's Alphitobius diaperinus larvae as a novel food.

European Commission Kicks Off 2023 With Batch of Novel Food Approvals

The European Commission has paved the way for some innovative dietary supplement launches in 2023 with the authorization of eight novel food applications.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153687

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel